Theme · live manifest · live theme JSON
MedTech Short '25: Heavy China Exposure
11 tickers · $1.07T total market cap
Group: MedTech Short
Even though the BIOSECURE Act did not pass in April, the Trump 2.0 administration has signaled ongoing hostility toward China-linked biopharma operations. De facto pressure is being exerted through executive actions, federal agency contract constraints, and rhetorical/political overhangs. That's already driving anticipatory behavior—such as supply chain restructuring, domestic capex shifts, and RFP rerouting—hurting multinationals with large China exposure.
MedTech Short '25: Heavy China Exposure tracks 11 publicly listed stocks in this theme: ABBV, AMGN, BMY, DHR, IQV, NVO, RGEN, SRT3.XETRA, TECH, WAT, ZLAB. See the constituent table for details.
Thesis update: 2025-04-14
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
AbbVie Inc.ABBV | 04/29/2026 (BMO) | 04/29/2026 (BMO) | -2.94% | 6.89% | -9.74% | 1.15% | $377.67B | 9.0909 |
Novo Nordisk A/SNVO | 05/06/2026 (BMO) | 05/06/2026 (BMO) | -19.92% | 2.07% | -4.92% | -3.32% | $196.78B | 9.0909 |
Amgen Inc.AMGN | 04/30/2026 (AMC) | 04/30/2026 (AMC) | 8.63% | -2.43% | -5.86% | 0.28% | $178.51B | 9.0909 |
Bristol-Myers Squibb CompanyBMY | 04/30/2026 (BMO) | 04/30/2026 (BMO) | 7.58% | 1.09% | -7.10% | 0.15% | $119.07B | 9.0909 |
Danaher CorporationDHR | 04/21/2026 (BMO) | 04/21/2026 (BMO) | -6.84% | -5.86% | -10.98% | -9.24% | $118.23B | 9.0909 |
IQVIA Holdings Inc.IQV | 05/05/2026 (BMO) | 05/05/2026 (BMO) | -7.43% | 9.65% | -14.16% | -1.86% | $28.90B | 9.0909 |
Waters CorporationWAT | 05/05/2026 (BMO) | 05/05/2026 (BMO) | -14.23% | 15.78% | -7.69% | -4.65% | $21.72B | 9.0909 |
Sartorius AGSRT3.XETRA | 04/23/2026 (BMO) | 04/23/2026 (BMO) | 3.77% | -7.96% | -3.82% | 0.58% | $17.60B | 9.0909 |
Bio-Techne CorporationTECH | 05/06/2026 (BMO) | 05/06/2026 (BMO) | 1.90% | -10.18% | -13.94% | -10.69% | $7.12B | 9.0909 |
Repligen CorporationRGEN | 05/05/2026 (BMO) | 05/05/2026 (BMO) | -2.41% | 6.39% | -10.54% | -13.71% | $6.12B | 9.0909 |
Zai Lab LimitedZLAB | 05/07/2026 (AMC) | 05/07/2026 (AMC) | -2.39% | -11.47% | 2.84% | -1.24% | $2.03B | 9.0909 |
| Average | -3.12% | 0.36% | -7.81% | -3.87% | $97.61B | 9.0909 | ||
| Median | -2.41% | 1.09% | -7.69% | -1.86% | $28.90B | 9.0909 | ||
| Std Dev | 8.34% | 8.39% | 4.68% | 4.88% | $112.12B | 0.0% | ||
| Min | -19.92% | -11.47% | -14.16% | -13.71% | $2.03B | 9.0909 | ||
| Max | 8.63% | 15.78% | 2.84% | 1.15% | $377.67B | 9.0909 | ||
| % Positive Tickers | 36.36% | 54.55% | 9.09% | 36.36% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.